Medical

One in 10 Australians have experienced depression and General Practitioners are often the first to treat these patients and maintain responsibility for their ongoing care. Major Depressive Disorder encompasses a range of symptoms which affect patients’ abilities to function in their daily lives, and in this interview we walk through this topic.  10 minute listen

For many, living with the symptoms of schizophrenia is complicated by their antipsychotic treatments, which can come with a range of side effects, such as metabolic syndrome, sedation and akathisia which may all impair patient functioning. In this interview we discuss a common problem facing GPs; that of choosing appropriate treatments for patients with schizophrenia, with a focus on brexpiprazole. 12 minute listen

This audio file contains all 6 interviews on this edition.

• Track 1, A different progestogen only pill option
• Track 2, Men: Mood disorder or something else?
• Track 3, PCI & dual antiplatelet therapy – How long is long enough?
• Track 4, The one question you should be asking patients of childbearing age
• Track 5, The essential role of primary care in the management of MDD in a pandemic landscape
• Track 6, Antipsychotic medications and their side-effects: Where REXULTI ^® (brexpiprazole) fits in

To view reference lists or product information please go to the individual tracks.

Aortic stenosis is present in about 3% of the population over 65 years and unfortunately up to 50% of people who develop severe aortic stenosis symptoms will not survive two years unless they have a valve replacement. Unfortunately, there is evidence that only two-thirds of patients with an established diagnosis of AS actually receive treatment, so we play a key role in the timely diagnosis and referral of our patients with suspected AS…..

Despite improvements in pharmacologic treatments, many patients with Heart Failure (HF) have severe and persistent symptoms and their prognosis remains poor. Patients with HF experience repeated hospitalisations and account for almost one in 50 deaths, equating to one person dying of HF every three hours. Several medical and device-related therapeutic interventions have been shown to improve survival, decrease hospitalisation and improve symptoms and quality of life. Listen to learn more…..

More than 190 million people globally have chronic venous insufficiency (CVI), and with increasing levels of obesity in the community, and an ageing population, venous disease is expected to place an increasing burden on the Australian healthcare system in the future. In the past decade there has been a move to minimally invasive techniques that provide, not only symptom relief, but improved quality of life and slow the disease progression, listen to learn more.   10 minute listen

When we talk about women’s health, bone health is not top of mind for many patients or physicians. Most of us don’t consider the importance of bone health until something goes wrong. Osteoporosis, like other chronic diseases, needs long-term treatment over a lifetime in most cases. The challenge remains in how to prioritise and not miss this “silent” disease, before a fracture occurs. In this interview we discuss the GPs’ role in identifying patients with risk factors for osteoporosis, diagnosing using DXA and initiating treatment to ideally prevent the first fracture, and certainly help to prevent the second.

At the start of 2021, the Royal Australian and New Zealand College of Psychiatrists released their updated clinical practice guidelines for mood disorders. This is the first update since 2015 and comes at a point of rapid change in the provision of mental health services. In this interview we talk about the changes to the guidelines and practical tips on implementing them in general practice.

GPs treating people living with schizophrenia often report encountering patients with adverse effects from long-term use of antipsychotics, such as weight gain, diabetes, hyperlipidaemia and lethargy. However it can be difficult for GPs to gain experience and confidence in changing antipsychotic medications, so in this interview we speak with a GP about their experience in this area.

Between the ages of 40 and 80 years, our total muscle mass is estimated to decline by 25% to 30%. Skeletal muscle plays a critically important role as a regulator of energy and protein metabolism throughout the body. As a result, age-related loss of muscle mass and strength can dramatically increase morbidity and mortality of otherwise survivable illness in older people. In this interview we talk about maintaining muscle mass in older adults.